This cohort study examines the association of incident use of tumor necrosis factor (TNF) inhibitors with subsequent decline in kidney function and risk of all-cause mortality among patients with new-onset inflammatory bowel disease (IBD). This evidence concerns the gene TNF and inflammatory bowel disease.